NeueHealth (NEUE) Expected to Announce Quarterly Earnings on Wednesday

NeueHealth (NYSE:NEUE - Get Free Report) is expected to issue its Q1 2025 quarterly earnings data before the market opens on Wednesday, May 14th. Analysts expect the company to announce earnings of ($2.51) per share for the quarter.

NeueHealth (NYSE:NEUE - Get Free Report) last issued its quarterly earnings data on Wednesday, May 14th. The company reported ($1.80) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($2.51) by $0.71. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%. The firm had revenue of $215.79 million for the quarter. On average, analysts expect NeueHealth to post $-9 EPS for the current fiscal year and $-9 EPS for the next fiscal year.

NeueHealth Stock Down 0.3%

Shares of NeueHealth stock traded down $0.02 on Monday, reaching $6.74. The stock had a trading volume of 12,385 shares, compared to its average volume of 20,600. The company has a 50 day moving average price of $6.47 and a 200 day moving average price of $6.33. The stock has a market capitalization of $60.17 million, a P/E ratio of -0.13 and a beta of 0.53. NeueHealth has a 1 year low of $3.79 and a 1 year high of $7.66.

Insider Buying and Selling

In other NeueHealth news, CEO George Lawrence Mikan III sold 12,440 shares of NeueHealth stock in a transaction that occurred on Friday, March 14th. The shares were sold at an average price of $6.13, for a total transaction of $76,257.20. Following the completion of the sale, the chief executive officer now directly owns 249,454 shares in the company, valued at approximately $1,529,153.02. The trade was a 4.75% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Jay Matushak sold 4,448 shares of NeueHealth stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $6.74, for a total transaction of $29,979.52. Following the sale, the chief financial officer now owns 41,592 shares of the company's stock, valued at approximately $280,330.08. The trade was a 9.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 68,178 shares of company stock worth $467,763 in the last three months. Corporate insiders own 64.30% of the company's stock.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.